# An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

> **NCT00002272** · NA · COMPLETED · sponsor: **Astra USA**

## Conditions studied

- Herpes Simplex
- HIV Infections

## Interventions

- **DRUG:** Foscarnet sodium

## Key facts

- **NCT ID:** NCT00002272
- **Lead sponsor:** Astra USA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002272, "An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00002272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*